Browse our anti-DYRK2 (DYRK2) Antibodies

Full name:: anti-Dual-Specificity tyrosine-(Y)-phosphorylation Regulated Kinase 2 Antibodies (DYRK2)

On www.antibodies-online.com are 107 Dual-Specificity tyrosine-(Y)-phosphorylation Regulated Kinase 2 (DYRK2) Antibodies from 0 different suppliers available. A total of 126 DYRK2 products are currently listed.

Synonyms:: 1810038L18Rik, DYRK2, fc18c09, si:ch211-266a5.8, wu:fa09g03, wu:fc18c09

list all antibodies	Gene Name	GeneID	UniProt
Anti-Human DYRK2	DYRK2	8445	Q92630
Anti-Mouse DYRK2	DYRK2	69181	Q5U4C9
Anti-Rat DYRK2	DYRK2	314862
Show all synonyms

Relevant Pathways for anti-DYRK2 Antibodies

Regulation of Carbohydrate Metabolic Process

More product categories related to DYRK2 Antibody

Top referenced anti-DYRK2 Antibodies

Human Polyclonal DYRK2 Primary Antibody for IHC (p), WB - ABIN391770 : Yamashita, Chujo, Tokuishi, Anami, Miyawaki, Yamamoto, Kawahara: Expression of dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 2 (DYRK2) can be a favorable prognostic marker in pulmonary adenocarcinoma. in The Journal of thoracic and cardiovascular surgery 2009 (PubMed)
Show all 6 Pubmed References

More Antibodies against DYRK2 Interaction Partners

Human Dual-Specificity tyrosine-(Y)-phosphorylation Regulated Kinase 2 (DYRK2) interaction partners

The expression level of DYRK2 was positively correlated with glioma pathological grade.
Results provide evidence that DYRK2 suppresses the proliferation of breast cancer cells and invasion through CDK14 (show CDK14 Antibodies) expression.
Study found that DYRK2 regulates liver metastases of colorectal cancer cells through the activation of EMT (show ITK Antibodies), and that patients with low DYRK2-expressing colorectal cancer liver metastases had worse outcomes than those with high DYRK2-expressing metastases.
our results delineate a novel mechanism of cancer stem cell regulation by the DYRK2-AR-KLF4 (show KLF4 Antibodies) axis. Restoration of the expression and function of DYRK2 is a potential therapeutic strategy against breast cancer stem cells.
lower DYRK2 levels were correlated with tumor sites, advanced clinical stages, and shorter survival in the advanced clinical stages. DYRK2 is a novel prognostic biomarker of human colorectal cancer.
Diminished DYRK2 expression sensitizes hormone receptor (show NR4A1 Antibodies)-positive breast cancer to everolimus by preventing mTOR (show FRAP1 Antibodies) degradation.
Findings indicate direct interaction of dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) with ring finger protein (C3HC4 type) 8 (RNF8) in regulating response to DNA damage.
the downregulated expression of DYRK2 in HCC (show FAM126A Antibodies) tumor tissues could promote the proliferation of hepatocellular carcinoma (HCC (show FAM126A Antibodies)) cells. In addition, reducing DYRK2 expression was associated with poor prognosis and Oxaliplatin resistance in HCC (show FAM126A Antibodies).
Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's Lymphoma
DYRK2 may regulate EMT (show ITK Antibodies) through Snail (show SNAI1 Antibodies) degradation in ovarian SA and might be a predictive marker for a favorable prognosis in the treatment of this cancer.

Zebrafish Dual-Specificity tyrosine-(Y)-phosphorylation Regulated Kinase 2 (DYRK2) interaction partners

data indicate that DYRK2 is expressed in the developing muscle progenitor cells in somites and that it positively regulates fast-twitch muscle differentiation, at least at the early stages
These results suggest that the phosphorylation of Dpysl2 (show DPYSL2 Antibodies) and Dpysl3 (show DPYSL3 Antibodies) by Cdk5 (show CDK5 Antibodies) and DYRK2 is required for the proper positioning of Rohon-Beard neurons and neural crest cells during neurulation in zebrafish embryos.

Mouse (Murine) Dual-Specificity tyrosine-(Y)-phosphorylation Regulated Kinase 2 (DYRK2) interaction partners

Dyrk2 regulates osteoclast fusion in a cell heterotypic manner.
DYRK2 regulates tumor progression through modulation of c-Jun (show JUN Antibodies) and c-Myc (show MYC Antibodies)

DYRK2 Antigen Profile

Antigen Summary

DYRK2 belongs to a family of protein kinases whose members are presumed to be involved in cellular growth and/or development. The family is defined by structural similarity of their kinase domains and their capability to autophosphorylate on tyrosine residues. DYRK2 has demonstrated tyrosine autophosphorylation and catalyzed phosphorylation of histones H3 and H2B in vitro. Two isoforms of DYRK2 have been isolated. The predominant isoform, isoform 1, lacks a 5' terminal insert.

Alternative names and synonyms associated with DYRK2

dual specificity tyrosine phosphorylation regulated kinase 2 (DYRK2) antibody
dual specificity tyrosine-phosphorylation-regulated kinase 2 (CpipJ_CPIJ014802) antibody
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (dyrk2) antibody
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (Dyrk2) antibody
dual specificity tyrosine phosphorylation regulated kinase 2 (Dyrk2) antibody
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) antibody

1810038L18Rik antibody
DYRK2 antibody
fc18c09 antibody
si:ch211-266a5.8 antibody
wu:fa09g03 antibody
wu:fc18c09 antibody

Protein level used designations for DYRK2

dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 , dual specificity tyrosine-phosphorylation-regulated kinase 2

GENE ID	SPECIES
452061	Pan troglodytes
6047972	Culex quinquefasciatus
8445	Homo sapiens
557602	Danio rerio
427864	Gallus gallus
69181	Mus musculus
314862	Rattus norvegicus
481152	Canis lupus familiaris
514916	Bos taurus

Did you look for something else?

Phone:	+1 877 302 8632
Fax:	+1 888 205 9894 (Toll-free)
E-Mail:	orders@antibodies-online.com